Newsroom

AUGUST 16, 2017 Glytec Announces Fourth FDA 510(k) Clearance for Its Market-Leading Diabetes Therapy Management Software The company’s eGlycemic Management System® featuring Glucommander™ has the broadest indications for use of any decision support solution for insulin titration. WALTHAM, MA — The pioneer of diabetes therapy management software, Glytec announces its fourth FDA clearance, adding...

DECEMBER 15, 2016 Glytec Grows its Patent Portfolio with Another Notice of Allowance for its Precision Diabetes Management Technologies This latest notice of allowance from the United States Patent and Trademark Office deepens Glytec’s intellectual property protections and further validates its leadership stature in the healthcare market. Waltham, MA — Glytec today announces another notice of...